• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电化学治疗乳腺癌皮肤大复发:一项 II 期临床试验。

Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial.

机构信息

Center for Experimental Drug and Gene Electrotransfer, Department of Oncology, Copenhagen University Hospital Herlev, Denmark.

出版信息

Acta Oncol. 2012 Jul;51(6):713-21. doi: 10.3109/0284186X.2012.685524. Epub 2012 Jun 26.

DOI:10.3109/0284186X.2012.685524
PMID:22731832
Abstract

BACKGROUND

Cutaneous recurrences of breast cancer may cause considerable discomfort due to ulceration, oozing, and pain and can also be difficult to treat. Electrochemotherapy is a localised anticancer treatment using electric pulses to make cell membranes permeable, augmenting uptake of chemotherapeutic drugs, and thus enabling highly efficient tumour cell kill. This is the first systematic investigation of electrochemotherapy for larger cutaneous recurrences of breast cancer.

PATIENTS AND METHODS

We conducted a phase II trial for patients with cutaneous recurrences where no further treatment options were available. Primary endpoint was objective response evaluated by clinical examination. Secondary endpoints included response evaluated by PET/CT, change in lung diffusion capacity, patient reported symptoms, and distress related to bodily appearance. Treatment consisted of bleomycin injection followed by application of electric pulses.

RESULTS

Seventeen heavily pre-treated patients received electrochemotherapy. Twelve patients were evaluable (follow-up > 8 weeks). CT showed four (33%) patients achieving over 50% tumour volume reduction, clinical examination showed one CR and one PR (OR 17%). Symptomatic relief included decreasing exudates, odour, and bleeding. Treatment was well tolerated; the main side effect was post-treatment pain.

CONCLUSION

This first phase II study indicates that electrochemotherapy is a promising treatment alternative for cutaneous recurrences of breast cancer.

摘要

背景

乳腺癌皮肤复发可导致溃疡、渗出和疼痛,给患者带来极大不适,且治疗较为困难。电化疗是一种局部抗癌治疗方法,利用电脉冲使细胞膜通透性增加,增强化疗药物的摄取,从而实现高效的肿瘤细胞杀伤。这是首次对较大面积乳腺癌皮肤复发进行电化疗的系统研究。

患者和方法

我们对没有其他治疗选择的乳腺癌皮肤复发患者进行了 II 期临床试验。主要终点是通过临床检查评估的客观缓解。次要终点包括通过 PET/CT 评估的缓解、肺扩散能力的变化、患者报告的症状以及与身体外观相关的不适。治疗包括博来霉素注射后应用电脉冲。

结果

17 名经大量预处理的患者接受了电化疗。12 名患者可评估(随访>8 周)。CT 显示 4 名(33%)患者肿瘤体积减少超过 50%,临床检查显示 1 名完全缓解和 1 名部分缓解(OR 17%)。症状缓解包括渗出物、气味和出血减少。治疗耐受性良好,主要副作用为治疗后疼痛。

结论

这项首次 II 期研究表明,电化疗是治疗乳腺癌皮肤复发的一种有前途的替代方法。

相似文献

1
Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial.电化学治疗乳腺癌皮肤大复发:一项 II 期临床试验。
Acta Oncol. 2012 Jul;51(6):713-21. doi: 10.3109/0284186X.2012.685524. Epub 2012 Jun 26.
2
Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients.基于博来霉素的电化学疗法:单机构52例患者的临床结果
Ann Surg Oncol. 2009 Jan;16(1):191-9. doi: 10.1245/s10434-008-0204-8. Epub 2008 Nov 6.
3
The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study.电化学疗法治疗乳腺癌根治术后持续性胸壁复发的疗效和安全性:一项 II 期研究。
Breast Cancer Res Treat. 2012 Aug;134(3):1169-78. doi: 10.1007/s10549-012-2095-4. Epub 2012 Jul 24.
4
Predicting patients at risk for pain associated with electrochemotherapy.预测有与电化学疗法相关疼痛风险的患者。
Acta Oncol. 2015 Mar;54(3):298-306. doi: 10.3109/0284186X.2014.992546. Epub 2015 Jan 16.
5
Electrochemotherapy of chest wall breast cancer recurrence.电化学疗法治疗胸壁乳腺癌复发。
Cancer Treat Rev. 2012 Aug;38(5):379-86. doi: 10.1016/j.ctrv.2011.07.006.
6
Electrochemotherapy: aspects of preclinical development and early clinical experience.电化学疗法:临床前开发及早期临床经验概述
Ann Surg. 2007 Mar;245(3):469-79. doi: 10.1097/01.sla.0000250419.36053.33.
7
Electrochemotherapy in treatment of tumours.电化学疗法治疗肿瘤
Eur J Surg Oncol. 2008 Feb;34(2):232-40. doi: 10.1016/j.ejso.2007.05.016. Epub 2007 Jul 5.
8
Calcium electroporation for treatment of cutaneous metastases; a randomized double-blinded phase II study, comparing the effect of calcium electroporation with electrochemotherapy.钙电穿孔治疗皮肤转移瘤;一项随机双盲 II 期研究,比较钙电穿孔与电化疗的效果。
Acta Oncol. 2018 Mar;57(3):311-319. doi: 10.1080/0284186X.2017.1355109. Epub 2017 Aug 17.
9
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.培美曲塞作为一线化疗药物治疗晚期或转移性乳腺癌的 II 期研究结果。
Breast Cancer Res Treat. 2011 Feb;126(1):101-8. doi: 10.1007/s10549-010-1286-0. Epub 2010 Dec 25.
10
Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases.静脉注射博来霉素的电化学疗法用于皮肤黑色素瘤转移灶的局部治疗。
Ann Surg Oncol. 2008 Aug;15(8):2215-22. doi: 10.1245/s10434-008-9976-0. Epub 2008 May 23.

引用本文的文献

1
Efficacy of gabapentin as pain management of T-T feline facial squamous cell carcinoma treated with electrochemotherapy.加巴喷丁对接受电化学疗法治疗的T-T型猫面部鳞状细胞癌的疼痛管理疗效。
Sci Rep. 2025 Jul 30;15(1):27874. doi: 10.1038/s41598-025-13767-w.
2
Prospective multicentre study of patients with cutaneous metastases from breast cancer treated with electrochemotherapy.乳腺癌皮肤转移患者接受电化学疗法治疗的前瞻性多中心研究。
Clin Exp Metastasis. 2025 May 29;42(4):32. doi: 10.1007/s10585-025-10350-5.
3
Arterial Infusion and Isolated Perfusion in Combination with Reversible Electroporation for Locally Relapsed Unresectable Breast Cancer.
动脉灌注和隔离灌注联合可逆性电穿孔治疗局部复发不可切除乳腺癌
Cancers (Basel). 2024 Nov 28;16(23):3991. doi: 10.3390/cancers16233991.
4
Electroporation with Calcium or Bleomycin: First Application in an In Vivo Uveal Melanoma Patient-Derived Xenograft Model.钙或博来霉素电穿孔:首次应用于体内葡萄膜黑色素瘤患者来源的异种移植模型
Pharmaceuticals (Basel). 2024 Jul 7;17(7):905. doi: 10.3390/ph17070905.
5
Safety and Feasibility of Vulvar Cancer Treatment with Electrochemotherapy.电化学疗法治疗外阴癌的安全性与可行性
Cancers (Basel). 2023 Jun 7;15(12):3079. doi: 10.3390/cancers15123079.
6
Calcium Homeostasis in the Development of Resistant Breast Tumors.抗药乳腺癌发展过程中的钙稳态
Cancers (Basel). 2023 May 23;15(11):2872. doi: 10.3390/cancers15112872.
7
Invasive and non-invasive electrodes for successful drug and gene delivery in electroporation-based treatments.用于基于电穿孔治疗中成功进行药物和基因递送的侵入性和非侵入性电极。
Front Bioeng Biotechnol. 2023 Jan 16;10:1094968. doi: 10.3389/fbioe.2022.1094968. eCollection 2022.
8
Electroporation and Electrochemotherapy in Gynecological and Breast Cancer Treatment.电穿孔和电化学疗法在妇科和乳腺癌治疗中的应用。
Molecules. 2022 Apr 12;27(8):2476. doi: 10.3390/molecules27082476.
9
Emerging immunotherapeutic strategies for the treatment of breast cancer.新兴的乳腺癌免疫治疗策略。
Breast Cancer Res Treat. 2022 Jan;191(2):243-255. doi: 10.1007/s10549-021-06406-1. Epub 2021 Oct 30.
10
Reduction of muscle contraction and pain in electroporation-based treatments: An overview.基于电穿孔治疗中肌肉收缩和疼痛的减轻:综述。
World J Clin Oncol. 2021 May 24;12(5):367-381. doi: 10.5306/wjco.v12.i5.367.